rs199898020
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001371333.1(DIABLO):c.179C>T(p.Ala60Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000355 in 1,613,524 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001371333.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DIABLO | NM_001371333.1 | c.179C>T | p.Ala60Val | missense_variant | 2/6 | ENST00000464942.7 | NP_001358262.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DIABLO | ENST00000464942.7 | c.179C>T | p.Ala60Val | missense_variant | 2/6 | 1 | NM_001371333.1 | ENSP00000442360 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000178 AC: 27AN: 151680Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000143 AC: 36AN: 251436Hom.: 0 AF XY: 0.000132 AC XY: 18AN XY: 135890
GnomAD4 exome AF: 0.000373 AC: 545AN: 1461844Hom.: 0 Cov.: 31 AF XY: 0.000351 AC XY: 255AN XY: 727224
GnomAD4 genome AF: 0.000178 AC: 27AN: 151680Hom.: 0 Cov.: 32 AF XY: 0.000122 AC XY: 9AN XY: 74004
ClinVar
Submissions by phenotype
not specified Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 23, 2023 | The c.179C>T (p.A60V) alteration is located in exon 3 (coding exon 2) of the DIABLO gene. This alteration results from a C to T substitution at nucleotide position 179, causing the alanine (A) at amino acid position 60 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jan 04, 2016 | The p.Ala60Val variant in DIABLO has not been previously reported in individuals with hearing loss and has been identified in 14/66736 European chromosomes by t he Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs1 99898020). Although this variant has been seen in the general population, its f requency is not high enough to rule out a pathogenic role. The alanine (Ala) at position 60 is not well conserved across species, with 1 mammal and several bird s and reptiles having a valine (Val) at this position, suggesting that a change to a valine residue at this position may be tolerated. Additional computational prediction tools do not provide strong support for or against an impact the prot ein. In summary, while the clinical significance of the p.Ala60Val variant is u ncertain. - |
not provided Uncertain:1Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Dec 16, 2021 | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; Variants in candidate genes are classified as variants of uncertain significance in accordance with ACMG guidelines (Richards et al., 2015) - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 04, 2023 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. ClinVar contains an entry for this variant (Variation ID: 228570). This variant has not been reported in the literature in individuals affected with DIABLO-related conditions. This variant is present in population databases (rs199898020, gnomAD 0.03%), and has an allele count higher than expected for a pathogenic variant. This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 60 of the DIABLO protein (p.Ala60Val). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at